Insiders, Special

Global reach: The top 25 biopharma companies in the world

Everyone likes to see a quick update on the list of the top companies in the industry, and the latest breakdown on big biopharma from GlobalData marked an opportunity I'm not going to let pass.

Of note, the data outfit flagged the debut of a Chinese company in the top 25 list. Chances are, we'll be seeing others join it as the industry undergoes a tidal shift toward Asia.

Other highlights include a significant drop in market cap for Celgene {$CELG} as it lost favor with investors and now tries to win some market respect back.

For those of you who like comparisons, you would have to add the top 4 companies on the list — the global players J&J, Pfizer, Roche and Novartis — to come up with one company big enough to rival Apple's $1 trillion market cap.

We did slightly rearrange this list to include a chart with updated market caps, so you could give it all some careful thought. Add them all up, and the sum of the 25 parts comes to $2.9 trillion. The distance from top to bottom marks a Grand Canyon of financial scale and reach. But what's interesting is how this list could change in the next 5 years.

Endpoints Insider

Endpoints Enterprise

Unlock this article along with other benefits by subscribing to one of our paid plans.
Already a subscriber? Log in now
← Go back

We produce two daily email newsletters designed to give you a complete picture of what's important in biopharma. It's free to subscribe and never any spam. Join 33,500+ biopharma executives who read Endpoints News every day.

Access is subject to the terms in our Privacy Policy.

The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 33,500+ biopharma pros who read Endpoints News by email every day.

Free Subscription